Sponsored Supplement
Cost-Effective Treatment Option for von Willebrand Disease
This supplement was neither developed nor peer reviewed by Journal of Clinical Outcomes Management. It is supported by Octapharma USA Inc.
April 1, 2019|Journal of Clinical Outcomes Management
Click here to read the supplement.
What can be done to provide a cost-effective treatment option for von Willebrand Disease?
Topics include:
- Review of Key Clinical Studies and Surgical Procedures
- Pharmacokinetics Comparison
- Pharmacoeconomic Comparisons